Introduction to EBM

7
1 EVIDENCE BASED MEDICINE NOEL L. ESPALLARDO, MD, MSc Knowledge Deteriorates in Time r = -0.54 p<0.001 ... ... . .. . . .... . .... .... ... .. ... Current knowledge on best care Years since graduation CME Activities are Mushrooming Big, and getting huge. Usually instructionally (knowledge) oriented. Results of an RCT About CME Quality of care rose slightly (statistically, but not clinically significant) in the Experimental Practices An identical rise was observed in Control Practices ! Celebrity Marketing Cybill Sheperd on menopause Kelsey Grammer on irritable bowel syndrome Richard Gomez and David Buenevasc on vitamin E Press Marketing Communications firm CCA

description

Introduction

Transcript of Introduction to EBM

  • 1EVIDENCE BASED MEDICINE

    NOEL L. ESPALLARDO, MD, MSc

    Knowledge Deteriorates in Time

    r = -0.54

    p

  • 2Political Endorsement

    GMA mulls sanctions vs drug companies

    only . . . is producing low priced drugs and

    only . . . is selling

    them.

    Philippine Star, Jul 22, 2002

    Pharmaceutical Influence

    0

    20

    40

    60

    80

    100

    120

    140

    0 3 6 9 12 15 18 21 24 27 30 33 36 39 42

    1ST COURSE2ND COURSE

    Pharmaceutical Influence

    0

    20

    40

    60

    80

    100

    120

    140

    0 3 6 9 12 15 18 21 24 27 30 33 36 39 42

    1ST COURSE2ND COURSE

    Pharmaceutical Influence

    0

    20

    40

    60

    80

    100

    120

    140

    0 3 6 9 12 15 18 21 24 27 30 33 36 39 42

    1ST COURSE2ND COURSEINVITATION

    Prescribing Practice

    Inappropriate prescription for cardiovascular diseases

    was very high

    Overutilized Drugs of Unproven Benefit

    calcium channel blockers

    anticholesterol drugs

    antioxidants

    Underutilized Drugs of Proven Benefit

    Beta blockers and diuretics

    aspirin

    What is Evidence-based Medicine

    Evidence-based medicine is the

    conscientious, explicit and judicious use of

    current best evidence in making decisions

    about the care of individual patients.

  • 3Evidence-based Medicine

    The practice of EBM requires the integration of

    individual clinical setting and expertise

    with the

    best available external clinical evidence from

    systematic research

    and the

    patients preference

    Case Scenario

    CriticalAppraisal

    ClinicalQuestion

    LiteratureSearch

    EvaluateApplication

    Apply Evidence

    EBM CYCLE

    A 72 year old female consulted in your

    clinic for hypertension and elevated

    cholesterol. During your discussion on

    cardiac risks, she inquires about the need to

    take an anti-cholesterol drug.

    What advise will you give to her?

    The PatientDecision Making

    in the Old Paradigm

    Pathophysiology Hypercholesterolemia promotes coronary artery

    disease thus cholesterol is a risk factor

    Common sense Lowering cholesterol also lowers the risk of

    coronary artery disease

    Experience If cholesterol is elevated by laboratory

    examination, it can be lowered by drugs

    Experts National Cholesterol Education Program: screen

    all adult patients and intervene when necessary

    The EBFCP Practitioner

    EBFCP practitioner

    Among elderly patients who have elevated cholesterol will anti-cholesterol drug be

    beneficial?

    The search

    MEDLINE

    Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the

    Scandinavian Simvastatin Survival Study

    Are the Results Valid

    Was the assignment of patients to treatments randomized?

    YES The title, abstract and the methodology section stated that the study was a double-blind randomized controlled trial

    Were all patients who entered the trial properly accounted for and attributed at its conclusion?

    YES 4,444 patients were randomized and analyzed according to intention-to-treat principle. In the table for the main analysis, the sum of patients in each group totaled 4,444, the number who were randomized

  • 4What are the Results

    How large was the treatment effect?

    Plac Tx

    Mortality 12% 8% RR .70

    RRR .30

    ARR .04

    NNT 25

    How precise was the estimate of the treatment effect?

    95% CI for relative risks of the different outcomes are less than 1

    Can the Results Help Mein Caring for My Patient

    Can the results be applied to my patient care?

    YES Subjects included in this study were patients with angina or MI and elevated cholesterol

    Were all clinically important outcomes considered?

    YES The main outcomes considered were new onset

    of MI, coronary death and overall cause of death

    Are the likely treatment benefits worth the potential harm and cost?

    NO The cost per life saved is 3.65 million

    Alternative Use of P 3.65 M

    For secondary prevention of death

    with anti-cholesterol

    drug

    3.65 M per life saved

    Other use of 3.65 M

    7 coronary by-pass surgery

    100 coronary revascularization (streptokinase) procedure in the ER including cost of ICU admission

    A 72 year old female consulted in your

    clinic for hypertension and elevated cholesterol.

    During your discussion on cardiac risks, she

    inquires about the need to take an anti-

    cholesterol drug.

    I would rather not give an anti-cholesterol

    drug. The benefit is too small for the cost it will

    take.

    What Advice Will You Give to the 72 year old Woman

    Avoid Nihilism EBFCP is Not About Statistics

    Are you the doctor who

    called my wife a

    standard error ? ! ? #

  • 5RCT on Critical Appraisal Study Design, Setting and Subjects

    Randomized controlled trial (cluster) Department of Family and Community Medicine Philippine

    General Hospital

    Medical interns

    Outcomes Knowledge Practice (scores and conformance to recommendations)

    history taking skills physical examination skills

    diagnostic skills appropriateness of non-pharmacologic intervention appropriateness of pharmacologic intervention

    Non-pharmacologic Intervention

    EBM Workshop

    Didactic Lecture

    Linear Regression Adjusted f or Clusters and Baseline Skills (p < 0.001)

    Mea

    n Sc

    ores

    30

    35

    40

    45

    50

    55

    60

    65

    70

    75

    80

    85

    Baseline Af ter Intervention

    EBM Workshop

    Didactic Lecture

    Linear Regression Adjusted f or Clusters and Baseline Skills (p = 0.113)

    Mea

    n Sc

    ores

    30

    35

    40

    45

    50

    55

    60

    65

    70

    75

    80

    85

    Baseline Af ter Intervention

    Pharmacologic Intervention

    EBM in Residency TrainingDFCM, U-PGH

    EBFCP CONFERENCE (Thursdays 7-8)

    Case presentation

    Questions about history and physical examination

    Diagnosis and differential diagnosis

    Disposition

    Formulate questions about the case

    Assign a reporter and facilitator for the following Thursday (educational prescription)

    EBM in Residency TrainingDFCM, U-PGH

    EBFCP CONFERENCE (Thursdays 7-8)

    Recall question

    How the search was done

    Appraisal of the searched article

    Resolution of the problem

    Can Appraisal of Guideline Improve Practice?

    Appraisal of CPG at DFCM had mixed results

    Before AfterDissemination

    7%

    30%

    Before AfterDissemination

    43%

    32%

    Appropriate Non-pharmacologic Treatment

    Appropriate Pharmacologic Treatment

    EBM and Quality of Care

    % Improvement in Appropriateness

    Feedback No Feedback

    Diagnosis 0 0

    History + 10 0

    Physical Examination + 13 - 3

    Endoscopy Request + 3 10

    Treatment + 25 - 3

    Follow-up Advice + 15 - 8

  • 6EBFCP ACTIVITIES

    RELEVANCE TO RESIDENCY RELEVANCE TO FUTURE PRACTICE

    BEFORE

    AFTER p-value BEFORE AFTER p-value

    Formulating question

    36.54 37.50 .917 32.70 41.67 .038

    Searching literature

    37.57 36.39 .789 35.34 38.80 .436

    Critical appraisal

    37.46 36.50 .824 35.76 38.34 .573

    Computation of stat

    36.30 37.76 .754 36.72 37.30 .904

    Applying to patients

    35.71 38.40 .430 33.07 41.27 .044

    Presenting 38.12 37.71 .624 39.00 34.83 .387

    EBM Acceptability Survey EBM Program Evaluation Objectives

    68% perceived that the objectives are attainable.

    Relevance and effectiveness of the activities 100% perceived EBFCP-QA-Research activities as relevant 97% would advocate the use in patient care 82% believed that EBFCP-QA activities were adequately applied

    in daily activities

    Areas for improvement clarify objectives, emphasizing applicability in actual practice,

    skills training, upgrading both the faculty skills and resource materials

    Decision Making: Old Paradigm

    Pathophysiologic understanding

    Common sense

    Experience

    Experts

    Others?

    Pathophysiology and Common Sense is Not Enough

    Plac Treat

    Cholesterol 1.0 -9.0

    Non-fatal MI 0.72 0.58

    Total MI 0.89 0.74

    Deaths 0.52 0.62

    Experts Cannot Agree on Effectiveness of Treatment

    1

    3

    5

    7

    9

    0% 20% 40% 60% 80%

    Experts vs. Evidence

    Management of asthma in general practice

    Steroids consider as first line maintenance

    PEFR monitoring should be done

  • 7Experts vs. Evidence

    Management of asthma in general practice

    Steroids confer minimal benefit but significant increase in cost to asthma patients in general practice

    PEFR monitoring is as good as symptom monitoring in general practice

    Experts Are Not Up-to-date

    1960

    1965

    1970

    1975

    1980

    1985

    1990

    4

    7

    10

    316

    1783

    2544

    0.5 1.0 2.0

    Favors Tx Favors Ctrl

    Ro

    uti

    ne

    Sp

    ec

    ific

    Ra

    re/N

    ev

    er

    Ex

    pe

    rim

    en

    tal

    No

    t

    Me

    nti

    on

    ed

    21

    6

    111281

    2 6

    5

    10

    878

    124

    3 1

    1 23

    2 65

    3 143

    11 265115 331117 392922 5452

    23 5767

    27 612530 634633 657143 2105954 2205165 4718567 4753167 48154 5

    15

    1 1 2

    87

    2

    p < 0.01

    p < 0.001

    p < 0.0001

    Decision Making in the New Paradigm

    Pathophysiologic understanding

    Common sense

    Experience

    Experts

    Others?

    Medical Evidence

    Keep on Asking

    Keep on Searching

    Keep on Learning